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Abstract 
In Canada, individuals with substance use issues continue to suffer devastating consequences and 
despite the implementation of a variety of evidence-based strategies, more efforts need to be 
made to address the problems surrounding substance use—as illustrated by the ongoing opioid 
epidemic. Several experts, professionals and scholars have increased their efforts advocating for 
a revision of current drug laws which has provided an opportunity to discuss the possibility of 
decriminalizing illicit substances for personal use. This paper utilizes secondary data applying a 
thematic analysis to conduct a narrative literature review regarding whether or not the Canadian 
government should support the decriminalization of illicit drugs. In an attempt to answer this 
question, it is important to acknowledge the adverse effects of the war on drugs, the legitimate 
solutions designed to reduce harm and recent initiatives that progress the harm reduction 
paradigm. The trends indicate an increasing acceptance towards adopting harm reduction 
policies. However, the lack of structural change/over-emphasis of medical aspects obstructs the 
effectiveness of harm reduction. Thus, policymakers should review current drug laws and 
seriously consider the possibility of decriminalizing illicit drugs for personal use and simple 
possession.  
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EXPLORING THE PROSPECT OF DECRIMINALIZING ILLICIT DRUGS IN 
CANADA 
Should the government of Canada support the decriminalization of illicit drugs for 
personal use? Much attention has been directed towards the benefits of removing criminal 
aspects regarding simple possession and personal consumption of illicit substances. This 
question is timely especially considering the recent progress that has been made in Oregon and 
Vancouver. Within the last few months, one state in America—Oregon—became the first to 
decriminalize personal use/possession of all drugs (Kim, 2020). This measure was passed 
securing 55.8 per cent of the majority’s vote. Shortly after, Vancouver councillors “…voted 
unanimously to ask the federal government to decriminalize possession of small amounts of 
illicit drugs” (The Canadian Press, 2020, para. 1). The city’s mayor emphasized the need to 
develop a health-focused approach. In October alone, 162 illicit drug deaths had been reported 
across the province of British Columbia: equating to five deaths daily (The Canadian Press, 
2020). The issue of substance use extends far beyond the realm of criminal justice, yet 
individuals suffering from substance use disorders continue to face devastating consequences 
perpetrated by the justice system. Accordingly, the objectives of this project could be valuable 
for policymakers, non-profit organizations and advocacy groups because the results outline the 
effectiveness of incorporating harm reduction principles into rules and regulations. Thus, 
bonafide efforts need to be made in order to amend the catastrophic effects of anti-drug policies. 
Methodology  
This paper implemented a descriptive research design. The purpose of this design is to 
describe individuals, events or conditions as they appear in the unchanged natural environment 
(Siedlecki, 2020). Descriptive designs produce hypotheses as opposed to testing them; although 
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this research design failed to definitively answer why Canadians should support the 
decriminalization of drugs, a descriptive design was still beneficial for describing how recent 
trends in policies, practices and interventions have incorporated harm reduction principles—
signifying a shift away from the traditional war on drugs. Furthermore, analyzing the contrast 
between the positive effects of harm reduction and the detrimental consequences that arose from 
punitive drug policies demonstrated how decriminalization is beneficial for society, helped 
specify the beneficiaries of decriminalization and clarified exactly what those benefits are.  
A semi-systematic review was incorporated into the descriptive research design. 
Decriminalizing drug use can affect multiple disciplines such as the health, law and economic 
sectors. Therefore, a full systematic review was not feasible because all articles regarding the 
decriminalization of drugs were not relevant for accomplishing the objective of this paper. 
Additionally, the semi-systematic approach provided insight into how research on 
decriminalization has progressed over time (Snyder, 2019). This approach emphasized 
transparency to ensure that readers can assess the rationality of the findings which helped reduce 
the lack of reliability of the descriptive research design. 
Conceptualization 
There are a few variables that must be conceptualized before attempts can be made to 
appropriately address/measure such variables. Regardless of prohibition, one variable that is 
central to this thesis is substance use. HealthLinkBC (2019) claimed: “the term ‘substance use’ 
refers to the use of drugs or alcohol, and includes substances such as cigarettes, illegal drugs, 
prescription drugs, inhalants and solvents” (Substance Use section, para. 1). Further, the term 
illicit drug possession refers to having, owning or controlling any drugs that are prohibited under 
the Controlled Drugs and Substances Act.  
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For the purpose of this paper, illicit drug possession refers to the simple possession of 
illicit drugs. Further, simple possession is in reference to the amount of drugs an individual 
possesses—which can help discern between drug traffickers and substance users. It is also 
important to define the two central approaches that were created to combat the consequences that 
stem from the manufacturing, distribution, possession and consumption of illicit drugs. The harm 
reduction approach refers to principles that are designed to minimize social, mental and physical 
health issues related to substance use and addiction problems (Canadian Mental Health 
Association, 2020). Whereas the primary focus of the war on drugs was to enforce harsh, 
punitive measures (Herrera, 2020). Finally, the differences between decriminalization and 
legalization should be addressed. Moreover, decriminalization refers to the removal of criminal 
penalties for simple possession/consumption of illicit drugs which allows the state to impose 
civil or administrative sanctions. Possessing or consuming illicit drugs would still be prohibited 
but certain components of the justice system like punishments and criminal records would be 
abolished; it is important to note this would not apply to drug traffickers (Alcohol and Drug 
Foundation, 2019). Legalization, on the other hand, involves regulations to manage the 
production, sales and consumption of illicit substances.  
Data collection 
This study utilized secondary data analysis to conduct a narrative literature review. A 
literature review critically examines sources that have already been published, and incorporating 
a systematic component provides an unbiased assessment of the literature (Jahan, Naveed, 
Zeshan & Tahir, 2016). Scholars have been researching and arguing for and against the 
decriminalization of illicit drugs for many years. This has produced lots of valuable data that can 
be used to understand the current status of illicit drug possession and how recent trends towards 
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harm reduction have prevailed over the traditional war on drugs. In this sense, a narrative 
overview was useful to not only summarize but also synthesize many pieces of information 
altogether into one article (Green, Johnson & Adams, 2006). Furthermore, this method is 
“…helpful in presenting a broad perspective on a topic and often describes the history or 
development of a problem or its management” (p. 103). In other words, this method allowed the 
researcher to present a broad perspective concerning whether Canadians should support or 
oppose decriminalization by analyzing how the negative effects of the war on drugs can be 
addressed via the implementation of harm reduction principles. 
The semi-systematic approach could potentially address the shortcomings of the literature 
review. Specifically, the semi-systematic approach combats risks of confirmation bias; “defining 
inclusion/exclusion criteria for literature selection can be helpful in focusing on the relevance of 
the studies to the topic” (Ferrari, 2015, p. 232). For this paper, inclusion criteria were limited to 
peer-reviewed journal articles and relevant newspaper articles that provided insight on recent 
trends in policies, measures and incentives. Search terms included: illicit drug decriminalization, 
benefits of harm reduction, war on drugs, drug regulation, social harms of drugs, drug 
criminalization and punishments related to substance use. Opinion pieces that lacked a peer-
review process and literature regarding over-the-counter drugs were excluded.  
The data sources accessed were peer-reviewed journal articles, books, de facto and de 
jure drug policies including legislative regulations, case law, crime rates and drug overdose rates. 
The two primary databases that were relied upon were the Mount Royal University Library 
search engine and Google Scholar. Analyzing a variety of sources helped describe the consensus, 
overall support and key reasons as to whether or not Canadians should support the 
decriminalization of illicit drugs.  
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Methods of analysis 
Critically evaluating previous research in the form of a qualitative thematic analysis 
allowed the author to address the descriptive objectives of the research design. Braun & Clarke 
(2006) argued: “thematic analysis is a method for identifying, analysing and reporting patterns 
(themes) within the data” (p. 79). Moreover, this form of analysis has been considered to be more 
accessible than different methods—such as a narrative/decomposition analyses—because prior 
theoretical and technological knowledge of approaches is not required when completing a 
thematic analysis (p. 81). What differentiates this method of analysis from others, is that a 
thematic analysis can allow the researcher to analyze themes/patterns within a data item rather 
than across entire data sets (p. 81). This was used to isolate specific policies, programs or 
principles in order to assess how effective they are at addressing certain issues associated with 
the criminalization of drugs. I began by generating initial codes as I am familiarized myself with 
the data. Sorting the initial codes into different sections (as outlined by the different headings) 
helped identify a variety of themes. Specifically, the codes were sorted into two broad categories; 
negative consequences and beneficial factors which were further divided into various 
subsections. The final step of the analysis involved reviewing, defining and naming the themes 
(pp. 91 & 92). Once the analysis was complete, synthesizing the data helped outline whether or 
not Canadians should support the decriminalization of drugs.  
The war on drugs 
Acknowledging the ideas, beliefs and principles that led to the enactment of various drug 
laws provides the necessary context required to understand why the war on drugs [WOD] 
resulted in such devastating consequences. Prior to the beginning of the twentieth century, 
marijuana, cocaine and heroin were regularly used; cocaine was an ingredient in Coca-Cola, 
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many department stores and pharmacies sold these drugs over the counter, and some of these 
drugs were even used to make cough medicines for children (Mallea, 2014). By the beginning of 
the twenty-first century, the unregulated market transformed “…legal access to drugs and 
relatively effective drug policy [became] social privileges restricted by race and social class” 
(Herzberg, 2017, p. 606). Additionally, understanding the United States approach to drugs is 
significant because it provided the framework which reinforced Canadian attitudes—and 
perhaps, the attitudes for most of the westernized world—as international consequences were 
introduced via the United Nations.  
Mallea (2014) highlighted how commerce of opium and cocaine became virtually 
impossible in 1914 with the enactment of the Harrison Narcotics Act. The purpose of this act 
was to deter irrationally drug-dependent consumers through prohibition and punitive policies 
(Herzberg, 2017). The act made it a requirement for distributors to register and pay taxes for 
importing, selling and distributing illicit substances (Lamb, 2015). Harrison Narcotics Act of 
1914 differentiated between rational and irrational drug users. Controversially, rational 
consumers were considered to use drugs for therapeutic purposes as these drugs were 
administered under physicians’ care—yet authorities also claimed that some physicians needed to 
be prosecuted for improper prescriptions, so what differentiated the two types of users was that 
rational consumers were not considered ‘junkies’ (Herzberg, 2017). According to Herzberg 
(2017), this backdoor cultural logic developed a social component to the concept of ‘medicines’ 
and ‘drugs’ creating a dual drug regime in which “…authorities increasingly agreed that 
addiction was a problem of street-hustling urban junkies and heroin, not of patients and their 
medicines” (p. 596).  
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The paradox of the rational consumer and the vilification of drugs that were administered 
under physicians’ care was furthered by the 1919 Supreme Court ruling of Webb v. United States. 
The outcome of this case forced many drug addicts to rely on illicit markets because physicians 
could no longer prescribe drugs to patients suffering from withdrawal symptoms (Lamb, 2015). 
At the same time, less White Americans were claiming addiction to morphine, this signified 
sellers/consumers of ‘medical drugs’ began to conform to their socially designated label of 
rational health seekers (Herzberg, 2017). On the other hand, nonmedical drug users also began to 
conform to their socially designated label of outsiders/outlaw junkies; allowing the dual drug 
regime to run rampantly (Herzberg, 2017). Furthermore, from 1931-1935, 70% of non-
registrants—street peddlers and consumers—were convicted by the Federal Bureau of Narcotics, 
whereas only 11% of registered physicians, pharmacists and wholesalers were convicted for the 
violations reported against them (Herzberg, 2017). Thus, substance use was historically available 
to all, but it became restricted to individuals that had privileged access to the medical system.  
The Canadian government took a similar approach to anti-drug laws, the rationale behind 
various legislations failed to account for scientific evidence and public health concerns. The 
Opium Act of 1908 declared that the importation, manufacturing and distribution of opium for 
non-medicinal purposes had become an indictable offence (Solomon and Green, as cited in Dana 
Brothers et al., 2003). Not surprisingly, Chinese manufacturers had to close their 
businesses while the medical industry continued to dispense opiates—primarily to White 
customers (Mallea, 2014). Tooley (1999) claimed the 1911 Opium and Drugs Act called for 
harsher penalties, signifying the ‘enforcement’ phase of Canadian drug policy (as cited in Dana 
Brothers et al., 2003). The significance of the origins of Canadian anti-drug laws is highlighted 
below.  
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The introduction of the 1908 Opium Act was influenced by the Deputy Minister of 
Labour, Mackenzie King, not by the ministers of justice or health (Dana Brothers et al., 2003). 
This simple yet crucial distinction alone speaks volumes about the objectives of anti-drug laws. 
Interestingly, with the completion of the Canadian Pacific Railway, the public’s fear of Chinese 
immigrants increased due to the fact that these immigrants were considered a source of cheap 
labour which had started to become an economic threat to other Canadians as job opportunities 
became limited (Dana Brothers et al., 2003). On September 7, 1907, a race riot in Vancouver 
called for Canadians to ‘Stand for a White Canada’, this led to property damage in Vancouver’s 
Chinatown, and created the spark that resulted in Mackenzie King’s influence which assisted in 
the introduction of the Opium Act (Mackay, 2018). Dana Brothers et al. (2003) indicated King 
was concerned that opium use had become more prevalent among White individuals while 
Chinese immigrants were profiting off opium sales. Furthermore, “the issue for the deputy 
minister of labour was not, in fact, about labour but, rather, about such things as the place of 
foreigners in Canadian society and the use of drugs by those foreigners” (Mackay, 2018, p. 536).  
It is also important to consider the role of international institutions. The United Nations 
Single Convention on Narcotic Drugs helped ascertain ‘westernized’ perspectives of substance 
use, creating an outright prohibition of certain drugs around the world (Mallea, 2014). For 
example, Zitt (2016) noted how withdrawal from the Convention could bring forth a damaged 
reputation, forced isolation and international sanctions. Boyd (1991), a professor instructing at 
the School of Criminology at Simon Fraser University, remarked: 
The United Nations power brokers who signed the 1961 Single Convention on 
Narcotic Drugs did not themselves have territorial control of the production and 
distribution of some of these drugs, including opiates…The power brokers did, 
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however, control alcohol, tobacco, and pharmaceuticals. These were thus deemed to 
be properly the subject of regulation rather than prohibition. (as cited in Mallea, 
2014) 
Furthermore, Nadelmann (1990) also brought attention to the development of global prohibition 
regimes, and how the objectives of such regimes coincided with dominant nations’ political, 
economic and moral interests. Moreover, USA had a pivotal role in the development of the 
Single Convention. The Single Convention took a prohibitive approach to tackle issues regarding 
substance use—as opposed to a regulatory perspective, as was done in earlier international drug 
control treaties—creating provisions intended to restrict the cultivation/production of drugs 
(Crick, 2012). Conveniently, the emphasis on ‘producer’ countries corresponded with the 
American narrative that substance use issues were rooted in external sources (Crick, 2012).  
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Corva (2008) noted the propaganda illustrated in figure one created a distinction that 
emphasized foreign production/distribution of illicit drugs as an exogenous national security 
threat that could destroy the domestic consumer, young White males. Ultimately, Canadian and 
American policies regarding the anti-drug rhetoric go beyond criminal and public health issues, 
venturing into the realm of deeply rooted social concerns. Before examining the outcomes of the 
WOD, it is crucial to understand the motives behind such policies.   
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Motives 
The WOD outlawed/penalized particular drugs while promoting a privileged use of other 
substances. A ‘war between drugs’ more accurately describes how the penalization of particular 
substances was driven by concerns about who uses drugs as opposed to public safety (Taylor, 
Buchanan, & Ayres, 2016). For instance, in 1937, the commissioner of the U.S. Federal Bureau 
of Narcotics claimed the most violence-causing drug in the world was marijuana, and “this 
marijuana causes White women to seek sexual relations with Negroes, entertainers and others” 
(Smith, 2018, as cited in Solomon, 2020, p. 3). Therefore, law enforcement agencies played an 
important role in the development of the American narratives that led to the WOD.  
Police bureaucracies were used as a primary source to justify the need for a WOD 
(Benson, Rasmussen, & Sollars, 1995). Unfortunately, misleadingly racist information 
characterized the foundations of anti-drugs policies; drug-related crime was strategically used to 
explain many societal imperfections. Police bureaucracies began to present anti-drug policies as 
a means of general crime prevention by associating substance use with non-drug crimes such as 
property damage and violence (Benson, Rasmussen & Sollars, 1995). Quite often, crime 
displacement and the disruption of drug markets failed to be accounted for.  
Moreover, police bureaucracies had a considerable amount of discretion regarding the 
allocation of their newly founded resources—the U.S. Attorney for the Eastern District of North 
Carolina highlighted the significance asset confiscations had for law enforcement agencies: 
“Drug agencies would have much less incentive to follow through on the asset potentially held 
by drug traffickers, since there would be no reward for such efforts…” implying that criminal 
prosecutions would deplete valuable time and resources (Benson, Rasmussen & Sollars, 1995, p. 
11). In more recent times, several conventions began to advocate for the need to combine law 
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enforcement agencies’ efforts regarding anti-drug and anti-terrorism policies as international 
organizations like the United Nations noted striking similarities between the WOD and the war 
on terror (Bjornehed, 2004). Narco-terrorism embodied this phenomenon.  
Although police bureaucracies played a crucial role in the establishment of anti-drug 
policies, it would be foolish to ignore the significance of the cultural attitudes that dispersed 
discourses of narco-dangers. Corva (2008) suggested that the WOD rhetoric rests upon absolute 
assumptions of free will in which individuals can ‘freely’ choose to partake in substance use, yet 
these assumptions failed to account for social, political and economic factors that may have 
influenced individuals’ decisions. This rhetoric of drug addiction allows socially advantaged 
individuals to emanate feelings of insecurity/hysteria amongst marginalized populations by 
assuming drug users ‘freely’ chose to make injurious decisions. Anti-drug policies based on such 
presumptions oppress minorities. “The criminalization of illicit drugs makes their economic 
viability dependent on a willingness to assume risk…this willingness is a condition clearly 
associated with the socioeconomically marginalised—those who have little to lose but their 
freedom” (Corva, 2008, p. 181). In simpler terms, criminalizing the vulnerabilities of 
marginalized populations creates a system in which the oppressed are faced with the revolving 
door phenomenon; resulting in what has been deemed as the prison-industrial complex.  
Outcomes 
The WOD has been costly, counter-productive and outright harmful to certain segments 
of the population. In Canada, similarities in substance use can be found amongst many racial 
groups, yet Black Canadians and Indigenous peoples are respectively five and nine times more 
likely to be arrested for possessing illicit drugs (Virani & Haines-Saah, 2020). Bobo & 
Thompson (2006) brought attention to the fact that the United States prison population remained 
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fewer than 300,000 for most of the twentieth century, however, the prison population began to 
increase around the 1980s—and had risen to over one million individuals by the start of the 
twenty-first century. Most of this increase could be attributed to the WOD, which called for a 
change to sentencing practices as opposed to changing the nature or frequency of drug crimes; 
nonviolent drug and property offenders contributed to a majority of the increase in prison 
populations (Mauer, 1999, as cited in Bobo & Thompson, 2006).  
Some may argue, the WOD intended to deter harms associated with substance use, but 
this counterargument fails to consider the privileged status of certain substances like alcohol. 
Currently, opioids are illegal in Canada even though alcohol consumption was the leading 
“…cause of hospitalization directly related to substance use…in 2017 – 2018, and three-quarters 
of deaths in hospital from substance use harms are due to alcohol” (Virani & Haines-Saah, 2020, 
p. 162). The privileged use of certain drugs is oftentimes situated in economic, political and 
cultural factors that further the vulnerabilities of socially disadvantaged individuals.  
Because police bureaucracies fuelled the drug war through incentivized motives, police 
departments were pressurized to show progress. Concentrating policing efforts in already 
disadvantaged neighbourhoods quickly demonstrated the ‘results’ that law enforcement agencies 
were pressured to secure. By 2004, Bobo and Thompson (2006) remarked, Black males 
accounted for 43.3 per cent of the American prison population but constituted merely thirteen per 
cent of the total population, whereas White males represented 75 per cent of the total population 
and just 35.7 per cent of inmate populations. In 2010 – 2011, 2.5 per cent of the total Canadian 
population represented Black individuals yet that same group reflected nine per cent of the 
federal prison population, depicting a 52 per cent increase from 2001 (Khenti, 2014). 
Interestingly, prison statistics more accurately represented the Canadian population in the 1980s, 
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prior to Mulroney’s pursuit of an American-style WOD; even when economic and household 
disparities existed between Black and White individuals (Khenti, 2014). Overall, scholars have 
argued that the over/under-representation of certain people appropriately reflected changes in 
social policies, laws and regulations as opposed to indicating the true nature of the crime.  
Oftentimes, the outcomes stemming from the WOD differed depending on the 
race/ethnicity of the perpetrators. The so-called ‘White drug war’ was a social privilege that 
made way for less punitive, decriminalized, clinical approaches to substance use by 
characterizing addiction as a biomedical disease (Netherland & Hansen, 2017). The National 
Institute on Drug Abuse spent millions of dollars linking neuroscience to drug dependency which 
“…ultimately [led] to a bifurcated discourse of White addicts as having a ‘brain disease’ and 
needing treatment, and non-White addicts as ‘criminals’ that require incarceration to protect the 
public” (Netherland & Hansen, 2017, p. 6).  
Rhetoric emphasizing a ‘brain disease’ was developed during the 1990s when heroin use 
began to rise in popularity amongst White middle-class individuals. Moreover, the WOD 
solutions that shifted from penalization to reformulation of pharmaceuticals represented social 
privilege. For example, Suboxone was developed to preserve the ‘whiteness’ of OxyContin as 
less privileged individuals began to abuse OxyContin when it crossed over into inner-city drug 
markets (Netherland & Hansen, 2017). Davis (2007) highlighted how Congress used terms like 
urban, suburban, new and hard-core drug users “…to create racial meaning that generates a sort 
of pathological profiling of groups without direct reference to race” (p. 351). The privileged 
narrative regarding neuroscience starkly contrasted previous implications that assumed 
individuals rationally chose to partake in substances—implications that led to diminished self-
esteem, mental health problems, enhanced levels of stigma and hopelessness for minorities. 
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Consequently, racial discrepancies coupled with mandatory minimum sentences strengthened the 
notion of the prison-industrial complex.  
It is never cheap to fund a war and the same goes for the WOD.  In 2002, the United 
States Office of National Drug Control Policy estimated that it cost nearly $181 billion to combat 
drug abuse (Sweet, 2009). Despite these expensive efforts, over the past few decades, drugs have 
become cheaper to obtain. A gram of cocaine cost as high as $350 in 1981 but that same gram 
could have been bought in 2003 for less than $100 (Sweet, 2009). The rise in prison populations 
attributed to financial costs as well. For instance, thirteen states spent more than $1 billion and 
California alone spent $8.8 billion on corrections, to put that into perspective, “in 2007, five 
states spent as much or more on corrections than on higher education” (Sweet, 2009, p. 232). In 
Canada, as far back as 1992, law enforcement agencies were funded $400 million while 
treatment services only received $88 million, and by 2008, Canadians were still combating 
substance use issues by allocating 70 per cent of funds to law enforcement initiatives despite 
more demands for treatment/prevention (Khenti, 2014).  This causes one to wonder about the 
possible beneficial outcomes if Correctional Services of Canada would allocate more resources 
towards prevention, treatment and harm reduction rather than spending vast amounts of money 
on operational costs to house drug-dependent inmates.  
The public’s support for the WOD has been waning. A multi-city study of attitudes about 
addiction discovered some residents of large metropolitan areas supported treatment and 
prevention-based approaches to combat drug issues as early as the mid-1990s (Lock et al., 2011). 
Many individuals had begun to perceive that America was losing the drug war. In addition to an 
increase in costs and a shift in the public’s support, individuals began to realize that law 
enforcement provided little benefits in combatting drug market violence. A systematic review 
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involving the relations between law enforcement efforts and illicit marketplace violence found 
prohibition likely contributes to drug-related violence and higher homicide rates (Werb et al., 
2011).  These paradoxical effects of law enforcement were witnessed in the classical historical 
examples that arose during alcohol prohibition, and “…after the removal of Columbia’s Cali and 
Medellin cartels in the 1990s… [which created] smaller cocaine producing cartels that 
increasingly used violence to protect and increase their market share” (p. 5).  
Canada was no exception to the failure of the WOD. Khenti (2014) claimed the WOD 
demonized Black men, intensifying interpersonal violence because of the lucrative drug trade; 
homicide rates among White individuals in Montreal were three per 100,000—as for their Black 
counterparts, the rates were estimated to be as high as 24 per 100,000. Policies and law 
enforcement efforts fell short in reducing the supply of or demand for illicit substances, all the 
while calls for evidence-based approaches became more appealing (Hyshka et al., 2018). Wood 
et al. (2004) examined data from the Vancouver Police Department’s large-scale ‘crackdown’ 
aimed at illicit drug users in 2003. It cost taxpayers $2.3 million but did not affect the frequency 
of drug use or drug prices. The city’s Downtown East-side crackdown simply resulted in the 
displacement of drug dealers and users (Wood et al., 2004).    
In conclusion, the origins of anti-drug policies—created before the WOD—were rooted 
in ulterior motives designed to subjugate the socially disadvantaged, in both Canada and the 
United States of America. Governments, courts, police bureaucracies and international 
conventions helped enforce and progress such motives for a majority of the twentieth century, 
and America has been at the forefront of the WOD. It therefore could be argued that there has 
been no coincidence, many of the devastating consequences stemming from the WOD have 
evolved from racist intents. Furthermore, flaws in the anti-drug rhetoric started to be taken 
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seriously when ‘special’ segments of the population became infected with a brain disease; 
simultaneously and coincidently, in the latter half of the 1990s as White middle-class individuals 
grew fond of opioids. Perhaps that is the reason why individuals have labelled such techniques as 
‘The New Jim Crow’ (Mallea, 2014). All in all, the WOD has been a complete and utter failure, it 
was never designed to solve the fundamental sociological, biological/medical and cultural issues 
that determine whether or not an individual will engage in substance use.  
The harm reduction approach 
Harm reduction may be considered as a relatively new perspective to combat drug use but 
in actuality concepts from this approach can be traced as far back as the 1980s. It is important to 
consider the definition of harm reduction before delving into the history of this approach. Lenton 
& Single (1998) proposed three conditions that are necessary in order to characterize a treatment, 
policy, or program as being a harm reduction intervention: reducing drug-related harm is the 
primary goal (as opposed to reducing drug use as the primary goal), both abstinence- and 
reduction-oriented strategies are included, and on a balance of probabilities, such strategies are 
“…likely to result in a net reduction in drug-related harm” (p. 216). It should be noted, reducing 
the frequency of drug use may be used as a strategy even though it is distinct from the primary 
goal which is to reduce drug-related harm. Thus, this approach does not exclude abstinence, 
rather it prioritizes the practicality of reducing harm. 
Risk reduction, harm minimization and more commonly known as harm reduction began 
to gain prominence in the mid-1980s as alternative solutions to the prevalence of AIDS/HIV 
amongst individuals that inject drugs (Vellemen & Rigby, 1990, as cited in Roe, 2005). In the 
1990s, public health officials, policymakers, and activists searched for alternatives to the WOD 
by working ‘around the laws’ to present a new view of criminal subcultures—communities in 
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need of medical interventions (Roe, 2005). This time frame is interesting to note because it was 
around the mid-1990s when the National Institute on Drug Abuse spent millions of dollars 
linking neuroscience to drug dependency developing the relatively new rhetoric of brain disease; 
this timely change in discourse unfolded as heroin use became popular amongst White middle-
class individuals. Perhaps, this is why Roe (2005) described historical tension within the harm 
reduction paradigm between medical means of promoting health and calls for social/structural 
change.  
Critics of medical interventions claimed the promotion of health could cause this 
approach to fall victim to the prohibitionist laws of the past, while critics of structural change 
place an emphasis on the unrealistic calls for social accommodations (Roe, 2005). In the past, 
harm reduction did not equate to the legalization or decriminalization of drugs, while defining 
the concept Lenton and Single (1998) highlighted the neutral stance that harm reduction took 
regarding the legality of illicit drugs. Some may argue the harm reduction approach still does not 
specify this, yet others claim that calls for societal change (an aspect of harm reduction) 
encompass the legalization/decriminalization of drugs (Roe, 2005). All in all, the legality of 
illicit drugs should be considered when analyzing the harm reduction approach, especially if 
decriminalization/legalization could result in a net reduction of drug-related harm.  
Canada’s progression of harm reduction can be observed through media coverage and 
policy implementation. Cameron Wild et al. (2019) analyzed 5681 articles, opinion pieces and 
reports about harm reduction published in Canadian newspapers between 2000 and 2016. This 
mixed-method, multiple-case study aimed to describe how harm reduction policies/services were 
positioned throughout Canada. It was discovered that media coverage shaped public discourse, 
often reflecting the views of elites through the frequency of coverage and selective prioritization 
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of specific strategies (Cameron Wild et al., 2019). This is concerning because it could be argued 
the WOD also shaped public discourse by reflecting the view of the elites. For example, nearly 
half of all the texts examined focused on supervised consumption sites despite its limited access 
due to a lack of availability, and “…coverage of needle distribution services…significantly 
decreased from 21% in era 1 to 3% in 2016. This shift was accompanied by a significant increase 
in naloxone coverage from 0% to 37%” (Cameron Wild et al., 2019, p. 8).  
Additionally, Cameron Wild et al. (2017) examined Canadian harm reduction policies 
that were implemented between 2000 and 2015, they found the frameworks guiding harm 
reduction policies often failed to account for managerial components and funding 
arrangements—resulting in a wide variation in the implementation of harm reduction services 
across Canada. Policymakers preferred to endorse generic concepts of harm reduction but were 
reluctant to support specific strategies as it was considered to be too politically contentious 
(Cameron Wild et al., 2017). Therefore, a variety of factors influence the implementation of 
evidence-based interventions.  
Generally, Canadian discourse supports harm reduction policies, but policymakers have 
been slow to implement specific strategies. A majority of the discourse is focused on medical 
perspectives. Cameron Wild et al. (2019) noted criminal justice perspectives on harm reduction 
were published in three per cent of the examined texts, whereas health perspectives were most 
commonly mentioned. Furthermore, only eleven per cent of the examined texts “…discussed 
general concepts and principles of harm reduction…prioritizing supervised consumption and 
naloxone for public consumption at the expense of other evidence-based services” (Cameron 
Wild et al., 2019, p. 8). The Canadian discourse on harm reduction has neglected the importance 
of societal/structural change such as availability of affordable housing, financial aids, 
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education/awareness…etc. Harm reduction once considered as a ‘bottom-up’ movement has now 
transformed into a ‘top-down’ policy; an emphasis is placed on individual consequences and 
societal costs as opposed to social causes of drug use (Roe, 2005). This strategic move allowed 
the entire harm reduction paradigm to steer clear from controversy by emphasizing the more 
saleable medical benefits of this approach (Roe, 2005). Overall, Canada made progress from the 
traditional WOD but failed to adopt the full potential of the harm reduction strategy.  
In a broader sense, there has also been international progress towards overcoming the 
WOD. The Single Convention of 1961 (mentioned earlier in the WOD section) was the first to 
unify international drug policy limiting the use, possession, production and distribution of illicit 
drugs. Mackey et al. (2014) highlighted how the effectiveness of such international drug control 
bodies have been questioned as the epidemic of global drug use has no end in sight. “At the same 
time, support for the international drug control governance regime and the policy approaches 
codified by these entities and instruments appears to be waning, with at least 30 countries 
enacting their own alternative approaches through domestic drug policy reform” (p. 2). Even the 
United States of America, notorious for the WOD, has made significant efforts to combat the 
issues stemming from anti-drug policies. The rise in support for pragmatic drug policies ensures 
the implementation of harm reduction strategies: syringe exchange sites, opioid agonist therapy, 
overdose prevention, supervised consumption sites, heroin-assisted treatment, Law Enforcement 
Assisted Diversion [LEAD], and the legalization/deregulation of marijuana are all sound 
examples of harm reduction interventions that were embraced by the Obama administration 
(Nadelmann & Lasalle, 2017).  
In Canada, the opioid epidemic alone highlights the need to adopt harm reduction 
strategies. The ‘iron law of prohibition’ refers to how the suppression/interruption of illicit drug 
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supplies tends to result in devastating consequences as more dangerous and concentrated 
compounds become obtainable (Tyndall, 2020). For instance, heroin and other pharmaceuticals 
have largely been replaced by fentanyl causing the death of over 6000 individuals in British 
Columbia alone, since 2014 (Tyndall, 2020). The aspect that makes this mass poisoning 
epidemic so tragic is the fact that “94% of opioid-related deaths in 2018 were accidental and 
preventable” (Government of Canada, 2019, as cited in Abidi et al., 2020, p. 114). Further, Abidi 
et al. (2020) argued harm reduction fundamentally rejects criminalization because this approach 
does not require individuals to abstain from using drugs. Ultimately, most individuals throughout 
society can agree the social, medical and judicial benefits of decreasing drug-related harms 
outweigh the devastating consequences that arose from the WOD.  
Intent 
Harm reduction aims to address the negative consequences of drug use. Harm reduction 
is pragmatic—the commonality of drug use requires containment/amelioration of drug-related 
harms as opposed to a complete elimination of drugs—no moralistic judgements are made, the 
focus is on reducing harm while balancing costs and benefits, and priority is placed on 
addressing immediate goals or the individuals most pressing needs (Riley et al., 1999). For 
example, in Australia, needle-syringe programs were relatively inexpensive to implement, 
reduced HIV incidents by 74 per cent, and saved costs returning approximately $1.3 to $5.5 for 
every dollar invested (Kwon et al., 2012, as cited in Wilson et al., 2015). Harm reduction is not 
some sort of new revolutionary strategy, rather it is an extension of already accepted approaches 
“…firmly rooted in public health practice to ‘secondary prevention’ with ‘high risk’ groups” 
(Riley et al., 1999, p. 19). Although harm reduction does not equate to legalization, many 
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advocates of this approach favour drug policy reform and some even support an outwrite 
legalization of all drugs (Riley et al., 1999).   
Many direct and indirect harms arise from individuals use of drugs. Supporters of the 
WOD may claim individuals autonomously decide to use drugs and are therefore responsible for 
the implications that emerge from their actions. However, this argument is flawed because the 
essence of harm reduction aims to return autonomy to the drug-addicted individual (Vearrier, 
2019). It is important to distinguish between dependence and addiction when trying to 
understand the concept of substance use disorders. Dependence refers to the need of using drugs 
to maintain normal functioning, whereas addiction implies an inability to control drug use; the 
distinguishing feature is that the former is a normal physiological response while the latter is an 
abnormal behavioural response (Vearrier, 2019). Thus, external sociological forces, disorders 
stemming from legitimate medical conditions or an inability to appreciate the risks, could hinder 
a drug addict’s decision-making capability. This autonomy argument illustrates the lasting 
impacts of the WOD rhetoric. For instance, the Canadian Centre for Substance Use and 
Addiction still emphasized abstinence as a central component in the recovery process (Bartram, 
2020). For these reasons, harm reduction is extremely important as it can potentially ‘bridge the 
gap’ between mental health and addiction recovery by explicitly excluding the requirement of 
abstinence (Bartram, 2020). Overall, harm reduction offers compassionate care and a lack of 
judgement by accepting individuals for whom they are while offering support to better their 
lives.  
Unlike the WOD, the harm reduction approach actually attempts to address the 
devastating issues of drug-related harms. Elkhalifa et al. (2020) argued social support could 
affect harm reduction and risk interactions because it was discovered that individuals were less 
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likely to suffer from an overdose if they reported having three or more sources of social support. 
The “…enabling environment comprises a wide range of micro and macro-level factors, all of 
which distil down to the interpersonal connections of individuals and their interactions with the 
environment” (p. 8). The impact of the environment is especially important to consider in terms 
of causes of drug-related recidivism. Typically, former inmates are released into socially and 
economically challenged environments that offer minimal structure and are coupled with 
ubiquitous drug activity (Binswanger et al., 2012). Accordingly, there is a need to reduce 
triggers, minimize the risk of relapse and overdose through community-based programs, offer 
transitional housing and other initiatives. Programs need to minimize the challenges of re-
entry—experienced by former inmates—by addressing medical, economic and housing needs 
(Binswanger et al., 2012). In contrast to the WOD, this approach aims to minimize harm through 
evidence-based interventions which address the underlying causes of drug use.  
Currently, harm reduction seems like the best option to combat the unlimited issues 
surrounding the use of illicit drugs. Ernst (2020) insisted the decriminalization of drugs is a 
central feature of harm reduction even after acknowledging that such reform has been criticized 
as the worst of both worlds—this is because decriminalization would fail to discourage use or 
prevent criminal organizations from profiting off individuals’ issues with illicit substances. The 
fundamental problem with the current stance regarding the legality of drug use is that it fails to 
consider how factors contributing to the prevalence of this ‘crime’ are rooted in the public health 
sector prior to being concerned with criminal law. Ernst (2020) highlighted: 
It cannot be denied that government intervention to control the production and 
distribution of drugs, especially hard drugs, is necessary and even desirable, but it 
should be noted that the imposition of penal sanctions for some style of drugs, 
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particularly partial and for personal use is, in fact, intrusion of legislator privacy of 
individuals and their privacy violation. (p. 20).  
Moreover, Portugal’s decriminalization approach which characterizes the possession of drugs as 
an administrative offence rather than a crime and Colorado’s legalization of marijuana, both 
provide great examples of the beneficial effects each strategy brings forth. Both strategies reduce 
harm, yet Portugal’s refined focus on healthcare, education and prevention of stigmatization 
proved to be more effective than Colorado’s regulation-based policies as they failed to embed 
health-focused protections (Smiley, 2016). Consequently, legalization created tax revenue which 
helped progress prevention efforts, while decriminalization directed governmental supports to 
those in need (Smiley, 2016).  
To summarize, the harm reduction approach provides sensible solutions to combat drug-
related harm while countering the catastrophic implications that arose from the WOD. While 
harm reduction does not necessarily equate to decriminalization, it is worthwhile to consider 
reforming current policies that originate from the oppressive discourse of the past. However, it 
would be ignorant to dismiss the shortcomings of this approach in pursuit of searching for better 
solutions to address drug-related harm.  
Shortcomings 
A majority of the shortcomings occur because of the social and cultural attitudes societies 
express towards people who use drugs. Erickson and Hathaway (2010) claimed that the status 
quo presented drug users as abnormal, conforming to the political agenda in which drug users are 
considered criminals, undeserving of harm reduction. In Canada, strategic contradictions can be 
witnessed at the federal level (Strike & Watson, 2019). The Liberal government, the driving 
force behind the legalization of marijuana, also “…signed on in support of a renewed war on 
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drugs led by the United States (Nolen 2018), leaving many to question how genuinely supportive 
the government is of harm reduction and drug policy reform. Decriminalization is not on the 
agenda of the present federal government” (as cited in Strike & Watson, 2019, p. 180). This is 
particularly concerning considering that the criminalization of drug use constrains the 
effectiveness of harm reduction policies (Smye et al., 2011). Therefore, the WOD rhetoric is 
deeply embedded into cultural attitudes, which explains why the harm reduction approach is 
supported for its logical consistency but lacks the same magnitude of support for the 
implementation of such policies.  
Throughout Canada, the implementation of harm reduction policies varies across the 
country. Hyshka et al. (2017) discovered, two provinces accounted for nearly half of all harm 
reduction policy documents, while two other provinces only had one policy that was relevant to 
harm reduction—at the time of this study, Yukon Territory did not even have one policy 
document related to harm reduction. Furthermore, of the policy documents that were analyzed, 
only two documents out of the 54 were considered stand-alone policies; “…indicating that policy 
commitments to harm reduction rarely occur outside broader discussions… [highlighting how 
policy documents] are dominated by support for unspecified ‘harm reduction’ services…” 
(Hyshka et al., 2017, pp. 8 & 9). On the other hand, services that have already been implemented 
may also need to be reformed. McNeil et al. (2014) brought attention to the limited scope of 
harm reduction services as hegemonic forms of masculinity restricted access to supervised 
injection sites for some women and marginal men. Hence, greater diversity may be needed to 
ensure appropriate coverage of harm reduction services (McNeil et al., 2014). In summary, 
concerns about not being taken seriously, stigma and discrimination need to be addressed 
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through organizational restructuring to promote equitable, diverse and transparent policies and 
services (People with Lived Expertise of Drug Use National Working Group et al., 2021).  
Developments in the right direction 
Although the legalization of marijuana illustrated significant progress from the 
prohibitionist laws of the past, this paper aims to address whether unconventional drugs (like 
crack-cocaine, methamphetamines, opioids…etc.) should be decriminalized or not, therefore the 
benefits of legalizing marijuana are briefly mentioned and are followed by the more appropriate 
analysis of the implementation of the first legitimate supervised injection facility in not only 
Canada but the entirety of North America—Insite. The legalization of marijuana is believed to 
bring forth various benefits for the economic, social and public health sectors. Legalization could 
result in higher tax revenue, significantly reduce enforcement and incarceration costs, minimize 
the devastating impacts from criminal records, lessen children’s contact with the black market 
and help manage symptoms from adverse health effects/provide therapeutic benefits (Hajizadeh, 
2016). Such benefits seemed to be unfathomable during the WOD era. In 2013, 67 per cent of all 
drug offences documented through police reports were related to marijuana, and prior to 
legalization, “…marijuana policy and legal framework [was] associated with considerable 
government costs of approximately $500 million to $1 billion per annum (Nolin, 2002; Crepault, 
2014, as cited in Hajizadeh, 2016). Thus, it was quite rational to reform the inefficient marijuana 
laws.  
Equally, if not more important, was the development of one of the first unsanctioned 
supervised injection facilities in 1995 which operated as a peer-led group referred to as the Back 
Alley—shut down by the police after a year of providing service in the Vancouver area (Kerr et 
al., 2017). Insite, the first legally sanctioned facility, opened in the September of 2003 as 
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Portland Hotel Society [PHS] was granted an exemption from the Controlled Drugs and 
Substances Act by the Health Minister of Canada (Kerr et al. 2017). However, the Conservative 
government, newly elected in 2006, expressed their opposition against Insite and harm reduction 
(Kerr et al., 2017).  
Accordingly, Tyndall (2006) noted how ‘cultural change’ was needed in order to 
overcome the prevailing views about drug use and addiction (as cited in Hathaway & Tousaw, 
2007). Humanizing drug addiction was considered to be the foundational component that united 
supporters of safe injection sites (Hathaway & Tousaw, 2007). Thus, PHS challenged the 
Conservative government in the Supreme Court of British Columbia to prevent the closure of 
Insite, they succussed as it was considered unconstitutional to deny access to life-saving services, 
and the Conservative government appealed that decision (Kerr et al., 2017). The Court of Appeal 
ruled in favour of PHS, and the decision was appealed once again. Finally, the Supreme Court of 
Canada unanimously determined that denying Insite an exemption would contravene the 
principles of fundamental justice because “…Insite has proven to save lives with no discernable 
negative impact on the public safety and health objectives of Canada… (p. 139)” (Canada v. 
PHS Community Services Society, 2011, as cited in Kerr et al., 2017, p. 17).  
The benefits of Insite have been well documented by several scholars. Safe injection sites 
prevent overdoses, reduce the transmission of diseases, lessen the frequency of injecting in 
public, provides appropriate means to dispose of needles, and minimizes reliance on emergency 
medical services while simultaneously increasing access to health services (Jozaghi & Andersen, 
2013).  Some of the lesser-known benefits include the creation/imitation of a ‘refugee camp’ for 
vulnerable individuals, and more importantly, Insite has contributed to a cultural transformation 
that is more accepting of harm reduction (Jozaghi & Anderson, 2013). Many have now come to 
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accept the fact that the economic costs of operating Insite outweigh the potential costs associated 
with shutting down the facility. In addition to the thousands of arrests, court adjudications and 
correctional services costs, “…the end of [these] programs will cost Vancouver and British 
Columbia between $3,862,000 and $8,780,000 in additional health care expenses over the next 
two years” (Drucker, 2006, p. 3). Ultimately, attempts to control addiction through the criminal 
justice system has proved to be ineffective and uneconomical (Zlotorzynska et al., 2013). Insite’s 
exemption signified a willingness to adapt to efficient evidence-based strategies that reduce the 
harms suffered by a variety of individuals.  
Recent trends 
In the June of 2020, the BC Coroners Service recorded 175 overdose deaths caused by 
illicit drugs within a month, which is the worst it has been in the history of British Columbia 
(Tunney, 2020). The Premier of British Columbia, John Horgan, has been advocating for the 
decriminalization of the possession of illicit drugs for personal use, and the Public Prosecution 
Service of Canada has advised lawyers “…to avoid prosecuting simple drug possession cases 
unless major public safety concerns are at play…” (Tunney, 2020, para. 1). The Mayor of 
Vancouver, Kennedy Stewart, has also voiced his support for the decriminalization of simple 
possession (Larsen, 2020). Interestingly, the state of Oregon set precedent by approving a 
measure that decriminalizes the possession of all illicit drugs intended for personal use (Kim, 
2020). Instead of punishing those with substance use disorders, individuals now have the option 
to pay a small fine or may have to participate in an addiction recovery program (Gangdev, 2020).  
In Alberta, a daily charge of $40 for the ability to access and take shelter in publicly 
funded addiction treatment centres has been abolished as the costs will be covered directly by the 
provincial government (Smith, 2020). These funds may seem insignificant, yet two months stay 
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at the centre would cost an individual $2,400 (Smith, 2020). Furthermore, French (2020) 
reported “some families took out second mortgages to pay for addiction treatment”. Additionally, 
Health Canada has granted a few exemptions to palliative care patients allowing them to use 
psychedelics for end-of-life psychotherapy—intended to relieve suffering for those that are near 
the end of their lives (Dubinski, 2020). In the United States of America, the state of DC approved 
an initiative that went into effect this March which decriminalizes simple possession of natural 
psychedelics like psilocybin mushrooms, mescaline and ayahuasca (Beaujon, 2021). These 
recent trends indicate a shift towards harm reduction—and even decriminalization—symbolizing 
a change in discourse from the once prominent WOD to a more appropriate emphasis on public 
health and social structure.  
Discussion and recommendations 
As outlined earlier, it is quite evident that more efforts need to be aimed at enhancing the 
social aspects of harm reduction. Providing suitable/affordable housing, eliminating or 
substantially reducing the costs of accessing certain services, and minimizing the stigma and 
discrimination experienced by individuals with substance use disorders. Medical aspects of harm 
reduction—supervised injection facilities, needle-exchange programs, opioid substitution 
therapy, availability of naloxone—have been implemented based on extensive research, however, 
social components are still lacking. Thus, a change in policy, in the form of decriminalization of 
illicit substances could become the initial step towards bringing forth structural change to 
enhance the social aspects of harm reduction.  
Although harm reduction is considered to be policy-neutral, this should not eliminate the 
possibility of decriminalization as the potential benefits outweigh the costs of the prohibitionist 
approach. Additionally, future research should explore how criminalizing simple possession and 
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the personal use of illicit substances hinders the efficiency of harm reduction initiatives. 
Hathaway & Tousaw (2008) highlighted: “Internal inconsistencies arise from compromises 
between public health priorities and drug law enforcement” (p. 13). In this sense, the approach 
must go beyond a policy-neutral stance so that the harm reduction initiatives can reach their full 
potential.  
Lastly, current harm reduction initiatives should be reconsidered and revised to improve 
efficiency. For example, the latest edition of the PPSC handbook illustrates a step in the right 
direction, yet this initiative could be reassessed to save costs, time and limited resources. The 
resources associated with arresting, charging and adjudicating an individual could have been 
reduced if this directive had been explicitly implemented by law enforcement agencies. Although 
many agencies may be reluctant to adopt such a strategy, if the RCMP adopted this directive set 
out by the PPSC handbook, it could have set precedent for other municipalities to follow.       
Limitations 
A major limitation of the descriptive design study is that it cannot definitively answer the 
research question (Labaree, 2020). Hence, research findings are at risk of being non-
representative and unreliable, “…the validity of the results is highly dependent on whether the 
study sample is well representative of the population proposed to be studied…” (Aggarwal, 
2019, p. 36). Labaree (2020) also brought attention to the fact that descriptive research designs 
are hard to replicate as observational methods are often utilized. Consequently, a lack of 
replication may once again hinder the reliability of the findings.   
Overall, the consequences that emerged from anti-drug policies must be addressed 
through legitimate evidence-based strategies. When contemplating whether or not illicit drugs 
should be decriminalized, policymakers must acknowledge the discriminatory roots of the 
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prohibitionist regime, the inefficient use of current resources and lack of structural change 
required to enhance the benefits of harm reduction. The failure of the WOD and more 
importantly, the prominence of harm reduction strategies has challenged the fundamental 
assumptions that led to the endorsement of anti-drug laws which—very well could be argued—
were designed to criminalize marginal populations. Accordingly, there is a need to review the 
motives/intent and possibly revise the provisions of the Controlled Drugs and Substances Act.  
Ultimately, the government of Canada should consider decriminalizing illicit drugs for personal 
use.  
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